KEY FINDINGS
The Europe dry eye disease market is predicted to project a CAGR of 4.79% during the forecast period, 2023-2032. Factors such as the growing awareness regarding dry eye disease, the increasing prevalence of glaucoma, the rising geriatric population, and the surging market consolidation are predominately credited to the region's market growth.
MARKET INSIGHTS
Poland, Spain, France, the United Kingdom, Germany, Belgium, Italy, and Rest of Europe are assessed for the Europe dry eye disease market growth evaluation. Italy harbors an advanced healthcare industry, representing a significant market. Glaucoma, as well as retinal disorders, encompass the largest segments. However, dry eye disease is relatively smaller, with no insurance reimbursement offered for the treatment of the same. The Italian Medicines Agency (Agenzia italiana del farmaco, AIFA) is the public institution in the country overlooking the regulatory activities of pharmaceuticals. Further, dry eye disease is more frequent among women in Italy, increasing with age.
In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) oversees the quality, efficacy, and safety of health products and medicines for veterinary and human use and clinical developments. In addition, according to World Health Organization (WHO) stats, health expenditure raised in the past two decades. Furthermore, the presence of ophthalmic clinics boosts the analyzed market's demands in Belgium.
Whereas in Spain, the increasing healthcare expenditure on pharmaceutical development enables growth opportunities. Besides, approximately 42% of the population will be aged above 60 by 2050.
COMPETITIVE INSIGHTS
Leading firms operating in the market are Johnson & Johnson, VISUfarma, Novartis AG, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Europe Dry Eye Disease Market Forecast 2023-2032
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Air Pollution Is A Major Cause Of Eye Diseases
2.5.2. Covid-19 Contributed To A High Number Of Dry Eye Disease Cases
2.5.3. Asian Race Is At Higher Risk Of Developing Dry Eye Disease
2.5.4. Excessive Screen Time Can Induce Dry Eye Symptoms
3. Market Dynamics
3.1. Key Drivers
3.1.1. Introduction Of Novel Diagnostic Techniques For Dry Eye Disease
3.1.2. Launch Of Promising Pipeline Products For Dry Eye Disease
3.1.3. Growing Incidence And Prevalence Of Dry Eye Among Different Age Groups
3.2. Key Restraints
3.2.1. Risk Of Side Effects
3.2.2. Substitute Therapies
3.2.3. Expensive Specialty Products And Complex Reimbursement Scenario
4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Market Trends
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Value Chain Analysis
4.7.1. Research And Development
4.7.2. Manufacturing
4.7.3. Distributors
4.7.4. Post-Sales Monitoring
5. Market By Type
5.1. Otc
5.2. Prescription
6. Market By Product
6.1. Anti-Inflammatory Drugs
6.1.1. Cyclosporine
6.1.2. Corticosteroid
6.1.3. Other Anti-Inflammatory Drugs
6.2. Artificial Tears
6.3. Punctal Plugs
6.4. Secretagogues
6.5. Other Products
7. Market By Distribution Channel
7.1. Hospital Pharmacies
7.2. Independent Pharmacies And Drugstores
7.3. Online Pharmacies
8. Geographical Analysis
8.1. Europe
8.1.1. Market Size & Estimates
8.1.2. Europe Dry Eye Disease Market Drivers
8.1.3. Europe Dry Eye Disease Market Challenges
8.1.4. Europe Dry Eye Disease Market Regulatory Framework
8.1.5. Key Players In Europe Dry Eye Disease Market
8.1.6. Country Analysis
8.1.6.1. United Kingdom
8.1.6.1.1. United Kingdom Dry Eye Disease Market Size & Opportunities
8.1.6.2. Germany
8.1.6.2.1. Germany Dry Eye Disease Market Size & Opportunities
8.1.6.3. France
8.1.6.3.1. France Dry Eye Disease Market Size & Opportunities
8.1.6.4. Italy
8.1.6.4.1. Italy Dry Eye Disease Market Size & Opportunities
8.1.6.5. Belgium
8.1.6.5.1. Belgium Dry Eye Disease Market Size & Opportunities
8.1.6.6. Spain
8.1.6.6.1. Spain Dry Eye Disease Market Size & Opportunities
8.1.6.7. Poland
8.1.6.7.1. Poland Dry Eye Disease Market Size & Opportunities
8.1.6.8. Rest Of Europe
8.1.6.8.1. Rest Of Europe Dry Eye Disease Market Size & Opportunities
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Aft Pharmaceuticals
9.2.2. Alcon
9.2.3. Allergan Plc (Acquired By Abbvie)
9.2.4. Bausch Health Companies Inc
9.2.5. Johnson & Johnson
9.2.6. Lumenis
9.2.7. Novaliq Gmbh
9.2.8. Novartis Ag
9.2.9. Oasis Medical
9.2.10. Otsuka Pharmaceutical Co Ltd
9.2.11. Santen Pharmaceutical Co Ltd
9.2.12. Sentiss Pharma Private Limited
9.2.13. Sun Pharmaceutical Industries Ltd
9.2.14. Teva Pharmaceutical Industries Ltd
9.2.15. Visufarma
List Of Tables
Table 1: Market Snapshot - Dry Eye Disease
Table 2: Europe Dry Eye Disease Market, By Type, Historical Years, 2018-2022 (In $ Million)
Table 3: Europe Dry Eye Disease Market, By Type, Forecast Years, 2023-2032 (In $ Million)
Table 4: Europe Dry Eye Disease Market, By Product, Historical Years, 2018-2022 (In $ Million)
Table 5: Europe Dry Eye Disease Market, By Product, Forecast Years, 2023-2032 (In $ Million)
Table 6: Europe Dry Eye Disease Market, By Anti-Inflammatory Drugs, Historical Years, 2018-2022 (In $ Million)
Table 7: Europe Dry Eye Disease Market, By Anti-Inflammatory Drugs, Forecast Years, 2023-2032 (In $ Million)
Table 8: Europe Dry Eye Disease Market, By Distribution Channel, Historical Years, 2018-2022 (In $ Million)
Table 9: Europe Dry Eye Disease Market, By Distribution Channel, Forecast Years, 2023-2032 (In $ Million)
Table 10: Europe Dry Eye Disease Market, By Country, Historical Years, 2018-2022 (In $ Million)
Table 11: Europe Dry Eye Disease Market, By Country, Forecast Years, 2023-2032 (In $ Million)
Table 12: Europe Dry Eye Disease Market Regulatory Framework
Table 13: Key Players Operating In Europe Dry Eye Disease Market
Table 14: List Of Mergers & Acquisitions
Table 15: List Of Product Launches & Developments
Table 16: List Of Partnerships & Agreements
Table 17: List Of Business Expansions & Divestitures
List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter's Five Forces Analysis
Figure 3: Growth Prospect Mapping For Europe
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Value Chain Analysis
Figure 7: Europe Dry Eye Disease Market, Growth Potential, By Type, In 2022
Figure 8: Europe Dry Eye Disease Market, By Otc, 2023-2032 (In $ Million)
Figure 9: Europe Dry Eye Disease Market, By Prescription, 2023-2032 (In $ Million)
Figure 10: Europe Dry Eye Disease Market, Growth Potential, By Product, In 2022
Figure 11: Europe Dry Eye Disease Market, By Anti-Inflammatory Drugs, 2023-2032 (In $ Million)
Figure 12: Europe Dry Eye Disease Market, Growth Potential, By Anti-Inflammatory Drugs, In 2022
Figure 13: Europe Dry Eye Disease Market, By Cyclosporine, 2023-2032 (In $ Million)
Figure 14: Europe Dry Eye Disease Market, By Corticosteroid, 2023-2032 (In $ Million)
Figure 15: Europe Dry Eye Disease Market, By Other Anti-Inflammatory Drugs, 2023-2032 (In $ Million)
Figure 16: Europe Dry Eye Disease Market, By Artificial Tears, 2023-2032 (In $ Million)
Figure 17: Europe Dry Eye Disease Market, By Punctal Plugs, 2023-2032 (In $ Million)
Figure 18: Europe Dry Eye Disease Market, By Secretagogues, 2023-2032 (In $ Million)
Figure 19: Europe Dry Eye Disease Market, By Other Products, 2023-2032 (In $ Million)
Figure 20: Europe Dry Eye Disease Market, Growth Potential, By Distribution Channel, In 2022
Figure 21: Europe Dry Eye Disease Market, By Hospital Pharmacies, 2023-2032 (In $ Million)
Figure 22: Europe Dry Eye Disease Market, By Independent Pharmacies And Drugstores, 2023-2032 (In $ Million)
Figure 23: Europe Dry Eye Disease Market, By Online Pharmacies, 2023-2032 (In $ Million)
Figure 24: Europe Dry Eye Disease Market, Country Outlook, 2022 & 2032 (In %)
Figure 25: United Kingdom Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 26: Germany Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 27: France Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 28: Italy Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 29: Belgium Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 30: Spain Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 31: Poland Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 32: Rest Of Europe Dry Eye Disease Market, 2023-2032 (In $ Million)
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
